Medicine and Dentistry
Observational Study
100%
Biological Marker
68%
Antibiotics
67%
Adeno Associated Virus 2
54%
Antibiotic Therapy
54%
Patient Referral
54%
Pediatrics Patient
42%
Acute Hepatitis
31%
Pathogen
31%
Logistic Regression Analysis
31%
COVID-19
31%
Protocol Compliance
27%
Aeromonas
27%
Informed Consent
27%
Independent Reviewer
27%
Gastroenteritis
27%
Prevalence
27%
Emergency Care
27%
Antiinfective Agent
27%
Enzyme Linked Immunosorbent Assay
27%
Bacterial Pneumonia
27%
Patient Assessment
27%
Oxygen Therapy
27%
Comorbidity
27%
Autoantibodies
27%
COVID-19 Vaccination
27%
Serositis
27%
Myocarditis
27%
Partial Least Squares Regression
21%
Clinical Decision Making
18%
Feature Extraction
16%
Human Herpesvirus 6
13%
Patient Acuity
13%
Human Leukocyte Antigen
13%
Medical Care
13%
Liquid Chromatography-Mass Spectrometry
10%
Immunoglobulin G
9%
T Cell
9%
High Risk Population
9%
Human Adenovirus C
9%
Disease Predisposition
9%
Effect Size
9%
Immune Deficiency
9%
Clinical Prediction Model
9%
Socioeconomic Status
9%
Acquired Immune Deficiency Syndrome
9%
Human Immunodeficiency Virus
9%
Myocardial Disease
7%
Immunoglobulin M
7%
Penicillin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
86%
Biological Marker
81%
Antibiotics
67%
Adeno Associated Virus 2
27%
Antibacterial Therapy
27%
Comorbidity
27%
Infectious Agent
27%
C Reactive Protein
27%
Antiinfective Agent
27%
Enzyme-Linked Immunosorbent Assay
27%
Bacterial Pneumonia
27%
Autoantibodies
27%
Inflammation
27%
Myocarditis
27%
Syndrome
18%
Bronchiolitis
13%
Leukocyte Antigen
13%
Respiratory Virus
13%
Immunoglobulin G
9%
Human Adenovirus C
9%
Disease Predisposition
9%
HIV
9%
Infectious Complication
9%
Acquired Immune Deficiency Syndrome
9%
Immune Deficiency
9%
Myocardial Disease
7%
Penicillin
7%
Immunoglobulin M
7%
Escherichia coli
6%
Streptococcus Group A
6%
Enterovirus
6%
Influenza B
6%
Influenza A
6%
Immunoglobulin A
5%
Sepsis
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Immunology and Microbiology
Adeno Associated Virus 2
54%
Blood Plasma
27%
Leukocyte Count
27%
Infectious Agent
27%
Glycosylation
27%
Glycopeptide
27%
C-Reactive Protein
21%
Human Leukocyte Antigen
13%
Human Herpesvirus 6
13%
T Cell
9%
Human Adenovirus C
9%
Protein Processing
9%
Protein Expression
9%
Neutrophil Count
8%
